Study design and eligibility criteria
The clinical pharmacokinetic study was designed as an open-labeled, with a single oral dosing, and conducted under a fasting condition. Four healthy subjects were recruited according to the following inclusion criteria: 18—55 years old with a body mass index (BMI) of 18–30 kg/m